Understanding and managing brain chemistry and unconscious bias to drive revenue growth-Understanding and managing brain chemistry and unconscious bias to drive revenue growth

Understanding and managing brain chemistry and unconscious bias to drive revenue growth

Video Transcription

Video Summary

Mark Erskine, a sales consultant with 25 years’ corporate sales experience, presented on applying neuroscience and behavioral psychology to modern selling. He explained that the brain processes far more information than conscious thought can handle, so it relies on shortcuts and biases. Key biases discussed included affinity bias, first-impression “halo/horn” effects, expedience, safety, and confirmation bias.<br /><br />He argued that selling has become more virtual and transactional since COVID, reducing face-to-face cues and making it even more important to use “brain-friendly” techniques. He outlined several brain chemicals relevant to sales: dopamine for positive anticipation, testosterone for action, serotonin for rapport, cortisol for threat and resistance, oxytocin for trust through storytelling, and GABA for calm and reflection. He linked these to behavioral styles and emphasized matching language and approach to the customer’s profile.<br /><br />Erskine recommended practical tactics for virtual selling: shorter meetings, clear agendas, collaborative meeting goals, sparing use of slides, more active listening, better questioning, and allowing space for reflection. He stressed that people buy people, so salespeople must intentionally build trust and connection in a hybrid world.

Keywords

neuroscience

behavioral psychology

sales consulting

virtual selling

customer biases

brain chemicals

trust building

active listening

hybrid sales